REFERENCES
- Streng A, Wiegering V, Liese JG. Varicella in pediatric oncology
patients in the post-vaccine era-Analysis of routine hospital data
from Bavaria (Germany), 2005-2011. Pediatr Hematol Oncol. 2016
Oct-Nov;33(7-8):468-479.
- Düzgöl M, Özek G, Bayram N, Oymak Y, Kara A, Demirağ B, Karapınar TH,
Ay Y, Vergin C, Devrim İ. Varicella-Zoster Virus Infections in
Pediatric Malignancy Patients: A Seven-Year Analysis. Turk J Haematol.
2016 Dec 1;33(4):346-348.
- Meyers J, Logaraj M, Ramraj B, Narasimhan P, MacIntyre CR. Epidemic
Varicella Zoster Virus among University Students, India. Emerg Infect
Dis. 2018 Feb;24(2):366-369.
- Sung L, Heurter H, Zokvic KM, Ford-Jones EL, Weitzman SS, Freeman R,
Dupuis LL, Scheifele DW. Practical vaccination guidelines for children
with cancer. Paediatr Child Health. 2001 Jul;6(6):379-83.
- Lachiewicz AM, Srinivas ML. Varicella-zoster virus post-exposure
management and prophylaxis: A review. Prev Med Rep. 2019 Nov
6;16:101016. doi: 10.1016/j.pmedr.2019.101016. Erratum in: Prev Med
Rep. 2020 Dec 13;20:101283.
- Koka A, Saygin C, Uzunaslan D, Ozdemir N, Apak H, Celkan T. A 17-year
experience with ALL-BFM protocol in acute lymphoblastic leukemia:
prognostic predictors and interruptions during protocol. Leuk Res.
2014 Jun;38(6):699-705.
- Arora RS, Eden T, Pizer B. The problem of treatment abandonment in
children from developing countries with cancer. Pediatr Blood Cancer.
2007 Dec;49(7):941-6.
- Oberoi S, Trehan A, Marwaha RK, Bansal D. Symptom to door interval in
febrile neutropenia: Support Care Cancer. 2013 May;21(5):1321-7.